Banking giant massively resets Jazz Pharma stock price target
Changes in Wall Street price targets usually arrive in small increments. A few dollars up, a few dollars down, and sometimes a rating left untouched. UBS skipped that script with Jazz Pharmaceuticals (JAZZ). On May 19, UBS analyst Ashwani Verma upgraded Jazz Pharmaceuticals two notches, from ...